Autoantibodies to C-reactive Protein is a Common Finding in SLE, but not in Primary Sjögren's Syndrome, Rheumatoid Arthritis or Inflammatory Bowel Disease

By Sjöwall C.   Eriksson P.   Almer S.   Skogh T.  

Journal of Autoimmunity, Vol. 19, Iss. 3, 2002-11 ,pp. : 155-160

Academic Press

Access to resources Recommend Favorite

High-sensitivity C-reactive protein as pretransplant marker for acute rejection and cardiovascular morbidity

By Lauzurica R.   Pastor C.   Bayes B.   Fluvia L.   Bonet J.   Bonal J.   Ara J.   Romero R.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 392-393

Elsevier

Access to resources Recommend Favorite

Inhibition of sPLA2-IIA, C-reactive Protein or Complement: New Therapy for Patients with Acute Myocardial Infarction?

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 6, Iss. 2, 2006-06 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite

C-reactive protein, inflammation, and innate immunity

By Mortensen Richard  

Immunologic Research, Vol. 24, Iss. 2, 2001-10 ,pp. : 163-176

Humana Press, Inc

Access to resources Recommend Favorite

Atherosclerosis-Related Functions of C-Reactive Protein

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 10, Iss. 4, 2010-12 ,pp. : 235-240

Bentham Science Publishers

Access to resources Recommend Favorite